Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Biotage in connection with its acquisition of Astrea from KKR’s life science platform Gamma
Mandate

Vinge advises Biotage in connection with its acquisition of Astrea from KKR’s life science platform Gamma

February 15, 2023 M&A Capital Markets and Public M&A EU, Competition and Regulatory

Vinge advises Biotage AB (publ) (“Biotage”) in connection with its acquisition of Astrea Bioseparations (“Astrea”), a high-growth chromatography solutions provider from Gamma Biosciences (“Gamma”), a life sciences tools platform created and controlled by KKR.

The acquisition extends Biotage’s chromatography franchise into the higher-growth and larger bioprocessing segment, while also increasing exposure to biologics and advanced therapeutic customers.

The purchase price will be paid in new ordinary shares in Biotage, entailing that the KKR-controlled Gamma is expected to become the largest shareholder in Biotage, with an ownership of approximately 17 percent.

The transaction is subject to shareholder approval by the general meeting of Biotage and customary closing conditions, including approvals from the UK authorities.

Vinge’s team consisted of Matthias Pannier, Karl Klackenberg, Linus Adolfsson, Sebastian Saadieh, Elis Allmark (M&A), Dain Hård Nevonen, William Kåge, Joel Magnusson, Anna Svensson, Gabriel Chabo (Capital Markets), Sebastian Örndahl (Anti-trust), Sara Dahlros Sköld and Julia Hagelberg (VDR).

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

 Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026